We have invested more into ovarian cancer research than any other charity in the world. Meet our grantees and learn more about the strides they are making to advance our knowledge and treatment of this disease.
Snap Summary: OCRA-funded researchers discovered a potential key to reducing chemotherapy resistance, and reducing recurrence rates for the most common type of ovarian cancer…
Snap Summary: New findings could help develop better immune therapy for patients with the most common and lethal subtype of ovarian cancer. Dr…
This article was updated in October 2023 to reflect NCCN’s release of the 2024 Guidelines for Cervical Cancer Patients…
